
    
      This study evaluates the administration of T-VEC in non-melanoma skin cancer. The aim is to
      evaluate the effectiveness, safety and tolerability of T-VEC in patients with non-melanoma
      skin cancer through determination of local immune effects after repeated T-VEC injections.
    
  